New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
09:37 EDTIT, CFN, NUAN, TCK, IRG, PLD, THOR, PNG, DE, BG, RVBD, ITW, CMI, TEVA, ANR, OSK, CYS, SKULOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Alpha Natural (ANR) downgraded to Fair Value from Buy at CRT Capital... Riverbed (RVBD) downgraded to Market Perform from Outperform at FBR Capital... Skullcandy (SKUL) downgraded to Neutral from Buy at Roth Capital... Teva (TEVA) downgraded to Hold from Buy at Canaccord... Bunge (BG) downgraded to Hold from Strong Buy at Feltl... CYS Investments (CYS) downgraded to Neutral from Buy at Compass Point... Deere (DE) downgraded to Buy from Strong Buy at ISI Group... Cummins (CMI) downgraded to Buy from Strong Buy at ISI Group.. Oshkosh (OSK) downgraded to Buy from Strong Buy at ISI Group... Illinois Tool Works (ITW) downgraded to Buy from Strong Buy at ISI Group... Gartner (IT) downgraded to Neutral from Overweight at Piper Jaffray... ProLogis (PLD) downgraded to Hold from Buy at Stifel Nicolaus... Nuance (NUAN) downgraded to Hold from Buy at Stifel Nicolaus... CYS Investments (CYS) downgraded to Hold from Buy at Stifel Nicolaus... PAA Natural Gas Storage (PNG) downgraded to Market Perform from Outperform at Raymond James... Ignite Restaurant (IRG) downgraded to Outperform from Strong Buy at Raymond James... CareFusion (CFN) downgraded to Outperform from Buy at CLSA... Riverbed (RVBD) downgraded to Neutral from Buy at Lazard Capital... Thoratec (THOR) downgraded to Market Perform from Outperform at Northland Securities... Teck Resources (TCK) downgraded to Neutral from Overweight at JPMorgan.
News For ANR;RVBD;SKUL;TEVA;BG;CYS;CMI;DE;OSK;ITW;IT;PLD;NUAN;PNG;IRG;CFN;THOR;TCK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 >>
September 4, 2015
10:08 EDTOSKHigh option volume stocks
Subscribe for More Information
08:30 EDTTHORThoratec begins enrollment of Shield II U.S. clinical trial
Subscribe for More Information
September 3, 2015
10:03 EDTITWOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:42 EDTTHORLeerink medical supplies/devices analyst holds analyst/industry conference call
Medical Supplies & Devices Analyst Antalffy, along with St. Paul's Hospital & Vancouver General Hospital Cardiac Transplant Program Surgical Director, Dr. Anson Cheung, and San Rafaele Hospital Cardiac Catheterization Lab & Vascular Interventions, Dr. Antonio Colombo, assess Valtech's pipeline and potential market opportunity on an Analyst/Industry conference call to be held on September 3 at 12:30 pm.
09:36 EDTTHORLeerink medical supplies/devices analyst holds analyst/industry conference call
Subscribe for More Information
07:02 EDTANRCalifornia pension funds coal divestment bill passes, Reuters reports
Subscribe for More Information
06:54 EDTITWIllinois Tool Works upgraded to Buy from Neutral at Goldman
Goldman upgraded Illinois Tool Works to Buy and lowered its price target to $99 from $101. The firm views Illinois Tool Works' valuation as compelling and earnings will be more resilient than investors believe. Goldman believes the company's margin story still has room to expand driven by improved sourcing, amortization roll-off, product line simplification, and cost efficiencies.
September 2, 2015
13:21 EDTTHORHeartWare plunges after Valtech deal sparks downgrades
Shares of HeartWare (HTWR) have plunged after the company's acquisition of cardiac device maker Valtech, with multiple analysts struggling to find any particularly strong rationale for the deal. WHAT'S NEW: Raymond James' Jayson Bedford downgraded HeartWare to Market Perform from Outperform after the company announced Tuesday night that it agreed to acquire Valtech Cardio, an Israeli-based company focusing on heart valve devices. Bedford said he was "surprised" by the size of the deal, noting that the all-stock transaction is valued at roughly $430M and will see Valtech owning roughly 22% of HeartWare upon closing. The acquisition is simply not what Bedford "envisioned" for the company, said the analyst. His prior investment thesis was based upon HeartWare's potential to dominate the ventricular assist device market, an idea "validated" by St. Jude's (STJ) pending acquisition of Thoratec (THOR), said Bedford. That thesis has now been disrupted by last night's early-stage asset buy at a "steep price," raising the overall execution risk of HeartWare, the analyst tells investors. WHAT'S NOTABLE: HeartWare was also hit with a downgrade to Neutral by BTIG, with the research firm emphasizing that the transaction will bring significant dilution to the company's existing shareholders. Northland's Suraj Kalia was even more bearish this morning, saying that the acquisition "does not make sense," coming at an "astronomical" multiple for an asset with "no obvious complementarity" and different domain expertise. Valtech's Cardioband CE study involved just 45 patients and only 40% of those were followed up at twelve months, said Kalia, who contended that the study does not present an accurate picture of clinical viability. Heartware will have to invest "significantly" to get Valtech's technology through U.S. trials, said the analyst, and entering the transcatheter mitral valve repair market will also bring new competition in the form of Edwards (EW), Medtronic (MDT), Boston Scientific (BSX), St. Jude and Abbott (ABT). PRICE ACTION: Shares of HeartWare have dropped more than 19% in intraday trading to $65.98, dipping below their 52-week low in the process.
07:31 EDTOSKGlobal Hunter Securities to hold a conference
Subscribe for More Information
September 1, 2015
08:03 EDTTEVATeva announces U.S. availability of Zecuity transdermal patch system
Subscribe for More Information
06:06 EDTPLDMenlo Logistics announces partnership with Prologis
Menlo Logistics, a subsidiary of Con-way (CNW), announced a build-to-suit agreement with Prologis (PLD) for a new 70,000-square-meter regional logistics facility in Eindhoven, the Netherlands. The facility will be located at the Acht industrial park in Eindhoven, adjacent to the A2/N2 Eindhoven ring road, which offers direct access to Belgium and Germany, as well as Amsterdam to the north.
August 31, 2015
16:57 EDTOSKOshkosh announces additional 10M share repurchase authorization
Oshkosh announced that its Board of Directors approved an increase to its share repurchase authority. The new authorization is in addition to the unused portion of the company's previous share repurchase authorization and permits the company to repurchase up to an additional 10M shares of Oshkosh common stock. The authorization is open-ended and the company has not set any timeframe to use the authority.
16:12 EDTDEUBS to hold a conference
Subscribe for More Information
16:09 EDTDELongbow to hold a conference
Subscribe for More Information
07:45 EDTTHORThoratec discloses HSR waiting period in St. Jude Medical expired
Subscribe for More Information
05:59 EDTTEVAStocks with implied volatility below IV index mean; BIIB TEVA
Stocks with implied volatility below IV index mean; Biogen (BIIB) 37, Teva (TEVA) 31 according to iVolatility.
August 28, 2015
10:56 EDTANRPeabody surges despite downgrade amid bounceback in coal stocks
Subscribe for More Information
10:03 EDTIRGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:37 EDTIRGIgnite Restaurant initiated with a Buy at Sidoti
Target $8.
09:16 EDTANRMoody's downgrades Peabody to Caa1
Subscribe for More Information
1 | 2 | 3 | 4 | 5 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use